NCT06903494View on ClinicalTrials.gov

Assessment of the 1-year Relapse Rate in Patients with Pemphigus Treated According to the Revised Pemphigus PNDS

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

February 17, 2024

Study Completion Date

March 1, 2025

Conditions
Dermatology Disease
Trial Locations (1)

76031

Pascal, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT06903494 - Assessment of the 1-year Relapse Rate in Patients with Pemphigus Treated According to the Revised Pemphigus PNDS | Biotech Hunter | Biotech Hunter